Sex-specific differences in risk factors, comorbidities, diagnostic challenges, optimal management, and prognostic outcomes of heart failure with preserved ejection fraction : A comprehensive literature review
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
Due to hormonal variations, heart failure with preserved ejection fraction (HFpEF) remains prevalent in women and affects almost half of the heart failure (HF) patients. Given the yearly death rate of 10-30% and the unavailability of medications targeting HFpEF, the need arises for a better understanding of the fundamental mechanisms of this syndrome. This comprehensive review explores sex-specific differences in traditional risk factors; female-specific factors that may impact HFpEF development and response to therapy, including variations in hormone levels that may occur pre- and post-menopausal or during pregnancy; and disparities in comorbidities, clinical presentation, and diagnostic challenges. Lastly, the review addresses prognostic outcomes, noting that women with HFpEF have a poor quality of life but a higher survival rate. It also discusses novel biomarkers and precision medicine, emphasizing their potential to improve early detection and personalized treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Heart failure reviews - 29(2024), 1 vom: 28. Jan., Seite 235-256 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abubakar, Muhammad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Female-specific risk factors |
|---|
| Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10741-023-10369-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364879521 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364879521 | ||
| 003 | DE-627 | ||
| 005 | 20240301232142.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10741-023-10369-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM364879521 | ||
| 035 | |a (NLM)37996694 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abubakar, Muhammad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sex-specific differences in risk factors, comorbidities, diagnostic challenges, optimal management, and prognostic outcomes of heart failure with preserved ejection fraction |b A comprehensive literature review |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.03.2024 | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a Due to hormonal variations, heart failure with preserved ejection fraction (HFpEF) remains prevalent in women and affects almost half of the heart failure (HF) patients. Given the yearly death rate of 10-30% and the unavailability of medications targeting HFpEF, the need arises for a better understanding of the fundamental mechanisms of this syndrome. This comprehensive review explores sex-specific differences in traditional risk factors; female-specific factors that may impact HFpEF development and response to therapy, including variations in hormone levels that may occur pre- and post-menopausal or during pregnancy; and disparities in comorbidities, clinical presentation, and diagnostic challenges. Lastly, the review addresses prognostic outcomes, noting that women with HFpEF have a poor quality of life but a higher survival rate. It also discusses novel biomarkers and precision medicine, emphasizing their potential to improve early detection and personalized treatment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Female-specific risk factors | |
| 650 | 4 | |a Gynecardiology | |
| 650 | 4 | |a HFpEF | |
| 650 | 4 | |a Precision medicine | |
| 650 | 4 | |a Pregnancy | |
| 650 | 4 | |a Sex-specific differences | |
| 700 | 1 | |a Saleem, Ayesha |e verfasserin |4 aut | |
| 700 | 1 | |a Hajjaj, Mohsin |e verfasserin |4 aut | |
| 700 | 1 | |a Faiz, Haseeb |e verfasserin |4 aut | |
| 700 | 1 | |a Pragya, Aastha |e verfasserin |4 aut | |
| 700 | 1 | |a Jamil, Rosheen |e verfasserin |4 aut | |
| 700 | 1 | |a Salim, Siffat Saima |e verfasserin |4 aut | |
| 700 | 1 | |a Lateef, Ibrahim Khaleel |e verfasserin |4 aut | |
| 700 | 1 | |a Singla, Deepak |e verfasserin |4 aut | |
| 700 | 1 | |a Ramar, Rajasekar |e verfasserin |4 aut | |
| 700 | 1 | |a Damara, Ivan |e verfasserin |4 aut | |
| 700 | 1 | |a Shahid, Laraib |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Heart failure reviews |d 1998 |g 29(2024), 1 vom: 28. Jan., Seite 235-256 |w (DE-627)NLM095528180 |x 1573-7322 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2024 |g number:1 |g day:28 |g month:01 |g pages:235-256 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10741-023-10369-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2024 |e 1 |b 28 |c 01 |h 235-256 | ||